Immunotherapy, the promise for present and future of malignant pleural mesothelioma (MPM) treatment

Due to occupational asbestosis exposure, the incidence of malignant pleural mesothelioma (MPM) has continuously increased over the last 30 years, with a plateau anticipated around the year 2030 in Western countries. Molecular MPM carcinogenesis involves alterations of NF2, RASSF1, LATS2WT1, p16, as...

Descripción completa

Detalles Bibliográficos
Autores principales: Gounant, Valérie, Brosseau, Solenn, Zalcman, Gérard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669877/
https://www.ncbi.nlm.nih.gov/pubmed/34917175
http://dx.doi.org/10.1177/17588359211061956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669877/
https://www.ncbi.nlm.nih.gov/pubmed/34917175
http://dx.doi.org/10.1177/17588359211061956

Ejemplares similares